Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$354,779
+$15,364 QoQ
Shares Held
1,871
+8.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#982
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DAVIS R M INC holds $148,422,330 across 9 Drug Manufacturers - General names. AZN ranks #6 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
61,458 | $73,714,575 | |
| 2 | JNJ |
Johnson & Johnson
|
249,911 | $63,469,896 | |
| 3 | ABBV |
AbbVie Inc.
|
18,009 | $4,531,784 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,586 | $3,030,801 | |
| 5 | AMGN |
Amgen Inc
|
6,701 | $2,426,566 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
1,871 | $354,779 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,425 | $312,588 | |
| 8 | PFE |
Pfizer Inc
|
12,484 | $300,614 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $354,779 | 1,871 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $339,415 | 1,721 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||